HIF1A and gastric cancer: Interestingly, a recent study from Japan demonstrated lower efficacy of 5-FU-based chemotherapy in HIF-1α-expressing human gastric adenocarcinomas, strengthening the perception of HIF-1 as a pivotal factor in the determination of gastric cancer chemoresistance [31].